- Filed
- Apr 22, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 15, 2025 | 200.43M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.24B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.61B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.04B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.24B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $17.34B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $17.36B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 213.55M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $245.84M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $42.68M |
| Capex | Q1 2025 · Mar 31, 2024 | $24.08M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $239.79M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $10.76B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $10.38B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $3.13 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $357.59M |
| Net Income | Q1 2025 · Mar 31, 2024 | $662.98M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.73B |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.95B |